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multimorbidity: a qualitative study 
Abstract 
Background: Chronic obstructive pulmonary disease (COPD), a major cause of morbidity and mortality 
worldwide, often occurs in the presence of comorbidities, which may influence experience and 
management of the disease. No prior research seems to have gained perspectives of newly diagnosed 
primary care COPD patients in the context of multimorbidity. Aims: This qualitative study aimed to explore 
the impact of a new diagnosis of COPD in the context of multimorbidity and also sought to gain a better 
understanding of how patients react to the diagnosis and incorporate it into their lives. Methods: 
Participants were identified from a cohort of primary care patients with multimorbidity recently diagnosed 
with COPD. Data was collected via semi-structured interviews from nine male and eight female 
participants. Thematic analysis was performed and the data interpreted from a constructivist 
perspective. Results: Five core themes regarding COPD were induced: (i) reaction to diagnosis, (ii) impact 
on function and health behaviour, (iii) factors influencing self-management capacity, (iv) healthcare 
utilisation and (v) interplay of comorbidities. Most participants had difficulty recognising the importance 
of COPD and its long-term implications. For many, the salience of another chronic condition outweighed 
COPD. Self-management capacity and utilisation of healthcare services were challenged by low 
prioritisation of COPD among other comorbidities. Conclusions: This study provides an insight into how 
primary care patients feel about being diagnosed with COPD, as well as their prioritisation of the disease 
in the context of multimorbidity. It highlights the need for tailored education and personalised 
management incorporating patients' perspectives in primary care. 
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ARTICLE OPEN
Patients’ perspectives on the impact of a new COPD diagnosis
in the face of multimorbidity: a qualitative study
Sameera Ansari1, Hassan Hosseinzadeh1, Sarah Dennis1,2 and Nicholas Zwar1
BACKGROUND: Chronic obstructive pulmonary disease (COPD), a major cause of morbidity and mortality worldwide, often occurs
in the presence of comorbidities, which may influence experience and management of the disease. No prior research seems to
have gained perspectives of newly diagnosed primary care COPD patients in the context of multimorbidity.
AIMS: This qualitative study aimed to explore the impact of a new diagnosis of COPD in the context of multimorbidity and also
sought to gain a better understanding of how patients react to the diagnosis and incorporate it into their lives.
METHODS: Participants were identified from a cohort of primary care patients with multimorbidity recently diagnosed with COPD.
Data was collected via semi-structured interviews from nine male and eight female participants. Thematic analysis was performed
and the data interpreted from a constructivist perspective.
RESULTS: Five core themes regarding COPD were induced: (i) reaction to diagnosis, (ii) impact on function and health behaviour,
(iii) factors influencing self-management capacity, (iv) healthcare utilisation and (v) interplay of comorbidities. Most participants had
difficulty recognising the importance of COPD and its long-term implications. For many, the salience of another chronic condition
outweighed COPD. Self-management capacity and utilisation of healthcare services were challenged by low prioritisation of COPD
among other comorbidities.
CONCLUSIONS: This study provides an insight into how primary care patients feel about being diagnosed with COPD, as well as
their prioritisation of the disease in the context of multimorbidity. It highlights the need for tailored education and personalised
management incorporating patients’ perspectives in primary care.
npj Primary Care Respiratory Medicine (2014) 24, 14036; doi:10.1038/npjpcrm.2014.36; published online 14 August 2014
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is currently the
fourth leading cause of mortality worldwide and is expected to
become the third by the next decade.1 In Australia, 4% of all
deaths in 2006 were attributed to COPD.2 Primarily caused by
exposure to noxious particles or gases, COPD is an independent
risk factor for lung cancer3 and causes a progressive, irreversible
deterioration in patients’ quality of life.4
COPD often occurs in the presence of other chronic health
conditions, known as comorbidities,5 which might be related
(concordant), such as asthma or depression, or unrelated
(discordant), like diabetes or fibromyalgia.6 Irrespective of being
concordant or discordant, comorbidities may influence experience
and management of the disease by patients.7 This coexistence of
two or more chronic health conditions in the same individual is
known as multimorbidity,8 which is the rule rather than the
exception in primary care.9 Multimorbidity contributes to higher
healthcare utilisation with associated increase in time and costs,
especially in older adults.10 In 2008, multimorbidity data extraction
from two Australian primary care practices revealed respiratory
diseases to be the third most common domain.11
There are numerous clinical outcome measures available
to quantify the health-related impact of COPD and its
comorbidities,12,13 but a need exists for qualitative research to
better understand coping strategies in patients with COPD.14
Though there is a growing amount of literature about the impact
of comorbidities on COPD and vice versa,7,15–18 research focused
on patients’ experience of these interactions is limited.19,20 While
some studies have explored patients’ attitudes and beliefs of living
with the disease,21–23 there is a dearth of qualitative research
regarding patients’ perspectives on the impact of COPD
diagnosis.24 In particular, no studies seem to have focused on
the experience of newly diagnosed COPD patients with comor-
bidities, especially in primary care.
Our qualitative research study is an attempt to fill this gap by
exploring primary care patients’ perspectives regarding the impact
of a new diagnosis of COPD in the context of multimorbidity.
MATERIALS AND METHODS
Sampling and recruitment of participants
Participants for this qualitative study were drawn from a cohort of 254
patients who had taken part in the PELICAN (Primary care EarLy
Intervention for Copd mANagement) project,25 a recent randomised
controlled trial of case finding. The PELICAN participants were aged
between 40 and 85 years, had a history of smoking and were recruited
from primary care practices across Sydney. As shown in Figure 1, 140 of the
254 participants had been diagnosed with COPD during the trial, which is
considered a new diagnosis for the purpose of the qualitative study.
Among the 140, 117 participants met the inclusion criteria of this study by
having one or more preexisting comorbidity along with a new COPD
diagnosis (in the past 24 months).
Using maximum variation type of purposive sampling to ensure
diversity, the eligible sample of 117 was narrowed down to 30 prospective
participants based on gender, age, comorbidity count, severity of COPD
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(as defined by GOLD (Global initiative for Chronic Obstructive Lung
Disease)4), level of education, employment, social support and smoking
status. Of the 30 potential participants for the study, 4 were not reachable.
Among the remaining 26 approached, 4 were reported to be deceased, 3
declined and 19 consented to participate. There was one participant who
dropped out at the beginning of his interview citing personal reasons.
Another participant had to be excluded as it was revealed during the
interview that he had been diagnosed with COPD before the PELICAN trial.
The final study sample comprised nine male and eight female participants
aged between 43 and 84 years. Their demographic characteristics are
outlined in Table 1.
Data collection and analysis
Verbal and written consent was obtained from the participants and they
were informed of their right to withdraw from the study at any time. Due
Figure 1. Recruitment of participants.
Table 1. Demographic characteristics of participants (N= 17)
Code Participant characteristics
F1 Female, 48 years, lives alone. Completed some high school, unemployed. COPD GOLD I, 14 months since diagnosis, 3 comorbidities,
current smoker.
F2 Female, 62 years, lives alone. Completed some high school, volunteer. COPD GOLD II, 8 months since diagnosis, 3 comorbidities,
ex-smoker.
F3 Female, 43 years, lives with spouse and children. Tertiary education, student. COPD GOLD I, 19 months since diagnosis, 5 comorbidities,
ex-smoker.
F4 Female, 80 years, lives with spouse. Completed some high school, retired. COPD GOLD II, 15 months since diagnosis, 7 comorbidities,
ex-smoker.
M5 Male, 77 years, lives with spouse and child. Vocational training, retired. COPD GOLD I, 20 months since diagnosis, 5 comorbidities,
ex-smoker.
M6 Male, 84 years, lives with grandchild. Tertiary education, retired. COPD GOLD II, 19 months since diagnosis, 4 comorbidities, ex-smoker.
F7 Female, 66 years, lives with spouse. Tertiary education, retired. COPD GOLD II, 20 months since diagnosis, 5 comorbidities, quit smoking
following COPD diagnosis.
F8 Female, 59 years, lives alone. Completed some high school, unemployed. COPD GOLD I, 19 months since diagnosis, 6 comorbidities,
quit smoking following COPD diagnosis.
F9 Female, 52 years, lives alone. Completed high school, employed full-time. COPD GOLD I, 24 months since diagnosis, 2 comorbidities,
quit smoking following COPD diagnosis and resumed after a year.
M10 Male, 69 years, lives with spouse. Completed some high school, employed full-time. COPD GOLD I, 7 months since diagnosis,
1 comorbidity, current smoker.
M11 Male, 82 years, lives alone. Completed some high school, retired. COPD GOLD I, 14 months since diagnosis, 4 comorbidities, ex-smoker.
M12 Male, 82 years, lives with spouse. Vocational training, retired. COPD GOLD II, 5 months since diagnosis, 5 comorbidities, ex-smoker.
F13 Female, 69 years, lives with spouse. Completed primary school, retired. COPD GOLD I, 20 months since diagnosis, 4 comorbidities,
ex-smoker.
M14 Male, 62 years, lives with spouse and children. Completed some high school, self-employed. COPD GOLD I, 24 months since diagnosis,
1 comorbidity, current smoker.
M15 Male, 64 years, lives with spouse. Tertiary education, employed part-time. COPD GOLD I, 16 months since diagnosis, 7 comorbidities,
ex-smoker.
M16 Male, 78 years, lives with spouse. Tertiary education, retired. COPD GOLD I, 21 months since diagnosis, 4 comorbidities, ex-smoker.
M17 Male, 56 years, lives with spouse. Tertiary education, employed full-time. COPD GOLD I, 13 months since diagnosis, 1 comorbidity,
current smoker.
Abbreviations: COPD, Chronic obstructive pulmonary disease; GOLD, Global initiative for Chronic Obstructive Lung Disease.
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to widespread location of participants across the Sydney region and based
on evidence supporting the equivalence of telephone and face-to-face
interviewing,26 telephone interviews were determined to be the most
convenient mode of data collection. A semi-structured interview guide
(Box 1) was developed for the study. Of the final 17 participants, 16 were
interviewed via telephone while 1 participant was interviewed at home
because he was hard of hearing. Data was deemed to be sufficient
following these 17 interviews because saturation27 had been attained by
then. Data collection was conducted by SA and took place through late
April to early July 2013. The interviews simulated natural conversation
while ensuring the main topics were explored sufficiently. The average
duration of the interviews was 30min. All interviews were digitally
recorded and transcribed verbatim.
The research team held regular meetings to analyse every stage of data
collection and analysis. Preliminary thematic analysis28 and initial coding
commenced alongside data collection by listening to the recorded
interviews. As a result, the interview guide was slightly modified after
the first six interviews by addition of two probing questions. Following
transcription, the data was organised and axial coding performed with the
aid of NVivo 10 software. Thorough thematic analysis of the coded
interviews was done by repeated exposure to the fragmented data. Using
a constructivist29 approach of data interpretation, the coded narratives of
the participants were iteratively analysed by the research team to unravel
deeper meaning until a consensus was reached regarding the main
themes that made sense to the researchers. A thematic framework of 16
subthemes were induced and then categorised under five core themes.
Each transcript was analysed and interpreted separately by at least one
other team member to ensure inter-researcher reliability.
The study had ethics approval from the Human Research Ethics
Committee of UNSW Australia (HREC 10015).
RESULTS
Following data analysis, five core themes encompassing partici-
pants’ perspectives of the impact of COPD diagnosis were
induced, namely (i) reaction to diagnosis, (ii) impact on function
and health behaviour, (iii) factors influencing self-management
capacity, (iv) healthcare utilisation and (v) interplay of
comorbidities.
i) Reaction to diagnosis of COPD
The participants had mixed reactions to being diagnosed with
COPD, from emotional to rational, including denial. ‘It (COPD
diagnosis) was a big shock because the last cigarette I had was
back in 1979’—F13, ‘It didn’t surprise me because I’d smoked for a
long time’—M15.
Female participants in their fifties and sixties seemed
more concerned about the COPD diagnosis than their male
counterparts. Participants in their seventies and eighties had a
more positive attitude. They were more resigned towards
accepting an addition to the number of preexisting chronic
conditions and also seemed the most passive in terms of
incorporating COPD management into their lives. ‘Let’s face it,
I’m 80…a lot of it’s just getting older. You can’t stop old age…I’ve
got what I’ve got, so that’s it’—F4. The diagnosis increased the
participants’ awareness of their breathing and enhanced their
general perception of health.
ii) Impact of COPD on function and health behaviour
COPD had a functional impact on 12 of the participants due to
breathlessness, affecting domestic chores and outdoor mobility.
‘I can’t really walk fast anymore, I get puffed’—M16.
Social participation was occasionally restricted for the two
youngest participants, both females with mild COPD. ‘I can
struggle doing anything that takes a lot of effort. I don’t like big
days out with the family’—F3.
The diagnosis seemed to motivate all the participants to modify
their health behaviour in terms of trying to increase or keep up
physical activity as well as monitoring diet. ‘I’m trying to get a bit
more active, walk a bit more, just try and do a little bit of exercise,
a bit more than I used to…I’m doing something, I’m not just
sitting around’—F1.
Of the seven participants who were smokers at the time of
COPD diagnosis, three females quit smoking shortly after the
diagnosis whereas the others started working towards smoking
cessation. ‘I’ve had a couple of goes and it (quitting smoking) is a
difficult thing...I’ll get there’—M17.
iii) Factors influencing self-management capacity of COPD
Only six participants knew what their lung condition was called.
Those with other lung conditions at the time of diagnosis, such as
Box 1 Interview guide
1. Could we start by asking about your experience of being
diagnosed with a lung condition?
J How did you feel about it then and how do you feel
about it now?
J Has this condition changed the way you think about your
health?
J If yes, in what ways?
2. What do you call the lung condition?
3. How does the lung condition affect your daily activities
and/or social participation? (Example)
4. What treatment, if any, are you undergoing for the lung
condition?
J How do you financially manage the treatment of the
condition?
5. Have you conducted other health professionals besides your
GP for the lung condition?
J If yes, who are they?
6. What changes, if any, have you made in your daily life
related to the lung condition?
J Please give an example of a change.
J What changes have you made in your health-related
behaviour?
J What has helped and not helped you in this process?
7. Do you have other long-term health conditions?
J If yes, which ones?
J Which do you consider most important and why?
J How do these affect your daily life? (Example)
J Which condition has the biggest impact?
8. How do you manage your lung condition compared to your
other long-term health conditions?
J How does the lung condition affect your other illnesses
and vice versa? (Example)
J Which illness do you give highest priority? (Example)
J How does this priority affect what you do? For example,
when taking medicines, attending appointments with
doctors and other health professionals.
J Is it expensive to manage the medication costs for all your
health conditions?*
9. How easy or difficult is it for you to follow your health
providers’ advice for treatment of your health conditions?
J What makes it easy or difficult? (Example)
J How do you keep track of the various medications you
need to take for your health conditions?*
J What can health providers do to help you manage your
health conditions better? (Example)
10. Is there anything else you would like to tell us regarding
your health conditions?
*Added after the first six interviews.
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asthma, seemed confused about the symptoms and nature of
COPD. ‘I didn’t realise that I had asthma...the two conditions make
things very difficult’—M6.
Retired participants had better financial leverage compared
with those employed or on other benefits like ‘Closing the Gap’30
or ‘Newstart’.31 ‘It (medicine) would be a lot dearer if I wasn’t on
the concession sort of deal’—M11. For some, financial constraints
impaired comprehensive management of COPD due to low
affordability of healthcare. For instance, one participant had to
wait more than a year following diagnosis to consult a respiratory
physician.
Chronic depression hindered coping with COPD and so did
work-related stress, which caused one participant to resume
smoking. Some participants felt that their inherent motivational
capacity helped in coping with the COPD diagnosis, whereas
others relied on family, faith and/or philosophy. ‘I always try to
look after myself because I know what I’ve actually got to do as an
old bloke like me…I’ve got kids to look after so I’ve got to make
sure I then look after myself’—M14.
iv) Healthcare utilisation for COPD
Typically, the participants consulted their family physicians twice a
month, mainly to obtain scripts for COPD and other comorbidities.
The two participants with asthma visited their healthcare
providers more often for consultation regarding COPD. Among
the 17 participants, 8 took a daily dose of prescribed inhalers and
3 used an inhaler whenever necessary, whereas 6 of them
refrained from using COPD medication in spite of having been
advised to do so. ‘I didn’t have any breathing problems…It (COPD)
doesn’t affect any activities that I know of’—M5.
With the exception of one participant who switched general
practitioners following COPD diagnosis, many others were
satisfied with their healthcare providers. Some felt they could
better manage their health themselves, whereas one participant
voiced the need for personalised plans and support in terms of
smoking cessation. ‘Maybe a better plan for the smoking…It’s
individual, instead of lumping everyone in one group 'cause
everyone is different’—F9.
Though most participants relied heavily on their healthcare
providers for advice and support, there was an apparent lack of
communication between the participants and their physicians in
terms of COPD. ‘I know more about my body than what a doctor
does, I know what’s the matter with me. And sometimes you can
tell the doctor and they just don’t listen’—F8. Few participants
understood the salience of the disease enough to strike some sort
of balance between COPD and other comorbidities during their
general practitioner consultations.
v) Interplay of COPD and comorbidities
Comorbidity count of the participants ranged from 1 to 7, with
most taking medication for all their health conditions. Of a total
32 comorbidities, as shown in Figure 2, hypercholesterolaemia
was the most prevalent (31%), followed by hypertension and
arthritis (25%), depression (12%) and diabetes (9%).
Among the 17 participants, only 29% gave the highest priority
to COPD among all their health conditions. The importance of
COPD mostly outweighed hypercholesterolaemia, hypertension
and depression in this study, but was overshadowed by diabetes.
For those most impacted by arthritis, COPD was given higher
priority. ‘That (COPD) limits your whole life, doesn’t it really…
because you need the air’—F2.
Overall, the experience of multiple health conditions was
challenging in terms of consuming various medications and
scheduling different healthcare appointments. ‘You try all these




Analysis of our study results was driven by a constructivist
interpretation of the participants’ experiences of a recent COPD
diagnosis in the context of multimorbidity. Our findings indicated
that though the participants accepted the diagnosis, they did not
recognise the importance of COPD, mostly due to low awareness
of the disease and its long-term implications. This may explain the
participants’ suboptimal self-management capacity of COPD and
underutilisation of relevant healthcare. Low prioritisation of COPD
in view of other comorbidities could be explained by the fact that
the participants were recently diagnosed and also because most
of them had mild severity of the disease. The relationship between
COPD and its comorbidities was also an important aspect of our
study and has implications for COPD management in primary care.
Strengths and limitations of this study
We believe this study is the first to explore patients’ perspectives
regarding the experience and impact of a new diagnosis of COPD
in primary care patients with comorbidities. All the study
participants had early-stage COPD, unlike other qualitative studies,
which have focused on patients in its later stages.19,22 The
interviews served as a platform for some of the participants to
Figure 2. Various comorbidities experienced by the participants. X axis: types of comorbidities, Y axis: number of participants.
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voice their health-related concerns. The elapsed time between
COPD diagnosis and this study, which spanned 5–24 months,
might have affected the participants’ recollections of their exact
experience. However, this timespan probably resulted in obtaining
richer perspectives about living with COPD. As most of the
participants were of Caucasian origin, similar studies with diverse
ethnic backgrounds are recommended.
Interpretation of findings in relation to previously published work
Low knowledge has been reported even in later-stage COPD
patients by Barr et al.,20 which is a concern for healthcare
providers. As many participants gave COPD lower priority than
their comorbidities, there is a need for promotion of better
awareness among patients.22,23 As the participants had either mild
or moderate COPD, limitation of functional capacity and impair-
ment of quality of life were relatively less than that reported in
other studies where patients had higher severity of COPD.21,22
In line with previous research, gender disparity was evident
among the participants in terms of reporting functional
limitation.32,33 The fact that our female participants seemed more
open towards seeking professional help and had better success
with smoking cessation than their male counterparts, is on a par
with the findings of Watson et al.,32 who found that women are
more likely to report dyspnoea and seek smoking cessation
advice. On the other hand, work-related stress coupled with
anxiety and/or depression, complicated smoking cessation for
both genders in our study, which was also reported by DiNicola
et al.34
Misconception and confusion about the interrelated behaviour
of COPD and asthma poses a concern for management of patients
with an asthma-COPD overlap.35 Participants with discordant
comorbidities, such as diabetes or cancer, were able to prioritise
their conditions more clearly than those with concordant
comorbidities like asthma or sleep apnoea. Such competing
priorities add to the confusion and helplessness perceived from
our interviews, which was also noted by Sheridan et al.36
In spite of limited understanding of COPD, all our participants
understood cigarette smoking to be its main cause. This differs
from the findings of Boeckxstaens et al.,19 who reported a
reluctance among their participants to accept the association
between smoking and their COPD. Yet, some of our participants
seemed very passive in seeking help for smoking cessation. This
could be due to their sense of shame and self-blame24,36 for
having contributed to the occurrence of COPD.
Socioeconomic status of the participants had an impact on their
health perspectives. Level of education seemed to influence how
participants experienced and managed their various health
conditions. Those with tertiary education seemed to better
understand the significance and implications of COPD and
prioritise it more logically in view of their other comorbidities, as
noted by Hudon et al.37 Participants living with family were better
motivated and had a more positive outlook towards tackling their
health conditions, with greater control over smoking and their
overall health behaviour.19,38
A need for person-centredness, which has also been reported
by McDonald et al.,35 is vital for the management of COPD with
comorbidities and can improve patient adherence. In spite of
multimorbidity and increased health burden following COPD
diagnosis, there was a positive vein among our participants. This
resulted in better adaptation and coping to the new diagnosis
than expected, a finding that has also been noted in previous
studies.19,39
Implications for future research and practice
Low awareness and prioritisation of COPD, suboptimal self-
management capacity and complications presented by conflicting
comorbidities were the highlights of this study. Implications of
these findings for healthcare providers in terms of managing
COPD patients with comorbidities are a need for acceptance and
incorporation of patient perspectives in primary care, and
development of holistic care plans. In terms of future research,
our study could be a base for interventions aimed at improving
patient knowledge and self-management capacity. Also, the
patient–provider relationship needs to be explored in future
studies on COPD with multimorbidity.
Conclusions
Our qualitative study explored the perspectives of primary care
patients regarding the impact of a new diagnosis of COPD in the
context of multimorbidity. The key findings were limited under-
standing and low prioritisation of COPD in view of other
comorbidities. These findings suggest the need for tailored
education to increase awareness about COPD and activation of
these patients to improve their self-management capacity in the
context of multimorbidity. As COPD is typically diagnosed and
managed in primary care, this is the most suitable setting
for personalised management that incorporates patient’s
perspectives.
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